drugset / Trial / NCT01984138
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is investigating whether breast cancer patients who experience vaginal dryness while on anti-estrogen treatment could benefit from either vaginal estrogen or from a vaginal moisturizer called Replens.
Timeline
- Start
- 2013-09
- Primary completion
- 2025-06-03
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 7.5 ug | Intrathecal |
| Subject | Estradiol | Other / unclassified | 10 ug | Intrathecal |
| Comparator | Replens | Unknown | — | Intrathecal |